AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: TREMFYA (Janssen Biotech, Inc.) (tremfya.com)
This site is a textbook example of high-substance pharmaceutical communication where regulatory oversight forces a low BS score. While it relies on weary marketing clichés and ‘ratings theatre,’ the core of the content is built on hard clinical data and technical specifications. It is a low-BS destination for patients, provided they look past the ‘Actor portrayal’ imagery to the raw trial percentages.
Directly link the ‘clinical studies’ text to the published peer-reviewed journals or ClinicalTrials.gov identifiers to replace vague authority with forensic proof. Replace empty H2 slogans like ‘Your journey starts here’ with descriptive headers like ‘Dosing Options and Clinical Response Rates.’ Provide transparency for the review_count data by linking to a third-party review aggregator or a transparent internal methodology page. Finally, integrate Person schema for medical reviewers or the leadership team of the support program to close the ‘anonymous nurse’ authority gap.
The site exhibits high substance in its body text, specifically citing clinical results such as ‘7 out of 10 patients saw at least 90% clearer skin’ and ‘23% were in clinical remission at 12 weeks.’ However, the heading density is diluted by fluff markers like ‘Your journey starts here’ [H2] and ‘Break away with TREMFYA’ [H1], which offer zero informational value. Concept repetition is notable, with the ‘TREMFYA withMe’ support program restated across all four pages using nearly identical phrasing. Despite the marketing veneer, the specificity of technical data (e.g., IL-23 blocker, SC vs IV dosing) provides a high noun-to-power-word ratio.
If your primary content isn't server side, your site collapses into an empty shell for every LLM. Check your server side content exposure and confirm whether AI can extract anything meaningful at all.
There is virtually zero semantic drift between the homepage signal and the sub-page substance. The homepage H1 prompts the user to choose a condition, and the subsequent pages for Plaque Psoriasis, Psoriatic Arthritis, and Ulcerative Colitis deliver high-resolution clinical data and specialized support resources as promised. The transition from the hero promise of ‘clearer skin’ to the technical details of ‘guselkumab’ and its ‘mechanism of action’ is logical and consistent.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
Trust theatre is detected via the review_count metric (12 on Psoriasis, 10 on UC) which is present in the page data without any corresponding proof_links_count or visible, verifiable review text. This suggests the use of internal rating systems that lack external validation or transparency. While the site references ‘clinical studies,’ it frequently uses ‘Actor portrayal’ [IMG] and ‘Nurse Guides’ who ‘do not provide medical advice,’ creating a protective layer of distance between the brand and the substance of its claims.
The ratio of verifiable evidence to vague assertions is high. For every generic value proposition like ‘Long lasting,’ there is a specific metric such as ‘Clinical remission at 1 year’ with detailed percentage breakdowns for different dosing regimens (100 mg vs 200 mg). The presence of specific prescribing information links (TREMFYA-pi.pdf) provides a secondary layer of forensic proof that validates the consumer-facing claims.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The site utilizes standard pharmaceutical template fingerprints such as ‘Patient Resources’ and ‘Savings and Support’ blocks that are visually indistinguishable from competitors like Humira or Skyrizi. Clichés such as ‘Your journey starts here’ and ‘Break away’ match the value_prop_cliches expected in the industry. However, the unique claim of being the ‘only IL-23 blocker for UC to offer self-administration from the start’ differentiates the positioning enough to avoid a maximum commodity penalty.
The authority is well-established through robust MedicalWebPage schema and its direct association with Janssen/Johnson & Johnson. A minor gap exists in the mention of ‘Nurse Guides’ who remain anonymous and unverifiable, lacking Person schema or professional digital footprints. The technical implementation is professional, with clean heading hierarchies and comprehensive JSON-LD that supports the brand’s claim as a regulated medical authority.
The marketing tone is aspirational (‘Imagine being a million miles away’), but the performance claims are heavily grounded in documented clinical trials. The disconnect is minimal because every bold claim (e.g., ‘Visible healing of the intestinal lining’) is immediately followed by a statistical qualifier (‘34% achieved endoscopic remission’). The site effectively balances the ‘miracle drug’ marketing narrative with the ‘statistical reality’ required by regulatory bodies.
Medical Devices, Pharma & Biotech BS: TREMFYA (Janssen Biotech, Inc.) (tremfya.com)
The website perfectly aligns with the Pharma & Biotech industry, specifically focusing on Direct-to-Consumer (DTC) marketing for a prescription biologic. The content is heavily structured around therapeutic areas, clinical trial data, and regulatory safety requirements characteristic of FDA-monitored pharmaceutical products.
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The score was primarily driven by Trust Theatre (ratings without verified links) and Information Density (concept repetition and empty headers). The Commodity Fingerprint score reflects the standard pharma template usage, while the low Semantic Drift and high technical Authority kept the overall BS score within the 'Minimal BS' range.”